Haubruck H, Mauch L, Cook N J, Steffens U, Hunt N, Berthold H, Niemann H, Wirbelauer C, Northemann W
Department of Molecular Biology, ELIAS Entwicklungslabor, Freiburg, Germany.
Autoimmunity. 1993;15(4):275-84. doi: 10.3109/08916939309115749.
The cDNAs coding for human full-length and soluble thyroid peroxidase (TPO) were constructed, cloned into a baculovirus transfer vector and used for infection of Spodoptera frugiperda (Sf9) cells. The soluble TPO lacking 87 amino acids of the C-terminal transmembrane and intracisternal domains was designed as a fusion protein with a histidine-hexapeptide as an affinity ligand at its C-terminus. Whereas the recombinant full-length TPO was expressed mainly in an insoluble form in Sf9 cells, the recombinant soluble TPO was almost completely secreted into the culture medium. Both the full-length and the soluble TPO were purified by conventional methods and by a specific affinity chromatography using metal chelating matrix respectively, and tested for their autoantigenicity towards anti-TPO autoantibodies. The ELISA established with the purified recombinant soluble TPO as antigen demonstrated its specificity, practicability and reproducibility in screening of anti-TPO autoantibodies in sera of autoimmune thyroid patients. High correlation (r = 0.89, n = 175) was obtained between the soluble TPO and natural TPO prepared from human thyroid glands. Pathological sera (n = 200) were positively assayed with a significance of 91%.
构建了编码人全长和可溶性甲状腺过氧化物酶(TPO)的cDNA,将其克隆到杆状病毒转移载体中,并用于感染草地贪夜蛾(Sf9)细胞。将缺少C末端跨膜和池内结构域87个氨基酸的可溶性TPO设计为在其C末端带有组氨酸六肽作为亲和配体的融合蛋白。重组全长TPO在Sf9细胞中主要以不溶性形式表达,而重组可溶性TPO几乎完全分泌到培养基中。全长和可溶性TPO分别通过常规方法和使用金属螯合基质的特异性亲和层析进行纯化,并检测它们对抗TPO自身抗体的自身抗原性。以纯化的重组可溶性TPO作为抗原建立的ELISA在筛选自身免疫性甲状腺疾病患者血清中的抗TPO自身抗体时显示出其特异性、实用性和可重复性。可溶性TPO与从人甲状腺制备的天然TPO之间具有高度相关性(r = 0.89,n = 175)。对200份病理血清进行检测,阳性率为91%,具有统计学意义。